EssilorLuxottica Société anonyme (FRA:ESL)
Germany · Delayed Price · Currency is EUR 253.00
+0.90 (0.36%)
Last updated: Aug 12, 2025
Marinus Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 2,381 | 2,359 | 2,289 | 2,152 | 1,448 | 85 | Upgrade |
Depreciation & Amortization | 3,081 | 3,049 | 2,947 | 2,921 | 2,386 | 2,155 | Upgrade |
Loss (Gain) From Sale of Assets | 2 | 6 | 4 | 2 | 2 | 6 | Upgrade |
Asset Writedown & Restructuring Costs | 60 | 49 | 25 | 49 | 94 | - | Upgrade |
Stock-Based Compensation | 256 | 162 | 195 | 191 | 160 | 156 | Upgrade |
Other Operating Activities | -84 | -54 | -172 | -125 | 126 | -59 | Upgrade |
Change in Accounts Receivable | -94 | -133 | -159 | -105 | - | - | Upgrade |
Change in Other Net Operating Assets | -688 | -564 | -268 | -302 | 329 | 610 | Upgrade |
Operating Cash Flow | 4,914 | 4,874 | 4,861 | 4,783 | 4,545 | 2,953 | Upgrade |
Operating Cash Flow Growth | 1.95% | 0.27% | 1.63% | 5.24% | 53.91% | -10.49% | Upgrade |
Capital Expenditures | -1,551 | -1,522 | -1,531 | -1,572 | -1,030 | -650 | Upgrade |
Sale of Property, Plant & Equipment | 14 | 10 | 11 | 17 | 16 | 8 | Upgrade |
Cash Acquisitions | -1,823 | -1,755 | -114 | -965 | -7,078 | -133 | Upgrade |
Investment in Securities | -349 | -367 | -94 | -184 | 97 | 287 | Upgrade |
Other Investing Activities | 14 | 12 | 4 | 85 | -65 | 8 | Upgrade |
Investing Cash Flow | -3,695 | -3,622 | -1,724 | -2,619 | -8,060 | -480 | Upgrade |
Long-Term Debt Issued | - | 2,383 | 438 | - | 75 | 2,981 | Upgrade |
Long-Term Debt Repaid | - | -2,240 | -1,964 | -1,917 | -1,522 | -705 | Upgrade |
Net Debt Issued (Repaid) | 1,200 | 143 | -1,526 | -1,917 | -1,447 | 2,276 | Upgrade |
Issuance of Common Stock | 7 | 35 | 34 | 37 | 34 | 36 | Upgrade |
Repurchase of Common Stock | -694 | -274 | -271 | -431 | -317 | -159 | Upgrade |
Common Dividends Paid | -547 | -1,163 | -487 | -454 | -138 | -503 | Upgrade |
Other Financing Activities | -325 | -388 | -175 | -815 | -172 | -152 | Upgrade |
Financing Cash Flow | -359 | -1,647 | -2,425 | -3,580 | -2,040 | 1,498 | Upgrade |
Foreign Exchange Rate Adjustments | -238 | 88 | -114 | 83 | 166 | -123 | Upgrade |
Miscellaneous Cash Flow Adjustments | -1 | - | - | -1 | - | -1 | Upgrade |
Net Cash Flow | 621 | -307 | 598 | -1,334 | -5,389 | 3,847 | Upgrade |
Free Cash Flow | 3,363 | 3,352 | 3,330 | 3,211 | 3,515 | 2,303 | Upgrade |
Free Cash Flow Growth | 0.69% | 0.66% | 3.71% | -8.65% | 52.63% | -3.88% | Upgrade |
Free Cash Flow Margin | 12.35% | 12.65% | 13.11% | 13.11% | 17.73% | 15.96% | Upgrade |
Free Cash Flow Per Share | 7.28 | 7.29 | 7.39 | 7.21 | 7.89 | 5.25 | Upgrade |
Cash Income Tax Paid | 1,016 | 982 | 916 | 940 | 618 | 356 | Upgrade |
Levered Free Cash Flow | 3,072 | 3,238 | 3,167 | 2,519 | 3,791 | 2,753 | Upgrade |
Unlevered Free Cash Flow | 3,245 | 3,396 | 3,291 | 2,617 | 3,879 | 2,842 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.